These observations were made by the High Court Justice during hearing a batch of petitions asking for allotment of 50% seats in PG courses in private medical and dental colleges under government quota. According to PTI, he posed these questions when it was brought to his notice that the state assembly had passed a bill to exempt the state from NEET and the bill was pending approval by the President.
He also passed interim orders directing the Medical Council of India (MCI) to file an affidavit explaining the number of seats approved in PG and diploma courses in Tamil Nadu colleges and what was the procedure to fill these seats in the past academic year.
He also directed MCI to explain the steps taken by MCI to ensure that the seats were filled as per merits and regulations and quota. N Kirubakaran also said that the affidavit should also state the process to be adopted by the council for admission in the 2017-18 session.
The petition also sought the HC to direct MCI to allocate 50% seats in recognized PG and diploma courses in each specialty at all private medical colleges under government quota.
The judge also questioned MCI on its inaction to control institutes which were doling out degrees as a business transaction. He asked MCI what was it doing to control institutions which were not following guidelines. He said, "When the institutions collect huge amounts is it not your duty to monitor the institutions being an authority of giving approval to the institutions."
The Judge also asked MCI to disclose the amount spent on medical students in graduate and PG courses as per the budgetary allocation in this regard. MCI was also directed to state if it had digitalized the database of faculties in each medical institute. The High Court has adjourned the matter to April 3 for further hearing.
(With Inputs from Press Trust of India)
Click here for more Education News
Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.